Czechia· CZ-0085772

KYBERNIN P

A antithrombin iii product containing antithrombin iii + proteins, registered in Czechia by CSL Behring GmbH, Marburg. The same ATC class is registered in 11 of our 19 countries.

ATC B01AB02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedKYBERNIN PATCB01AB02REGISTER NO.CZ-0085772PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Antithrombin iii is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AB02 (antithrombin iii), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose

Antithrombin iii · ATC B01AB02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
ANTITHROMBIN III + PROTEINS
Manufacturer
CSL Behring GmbH, Marburg
Country
Czechia (CZ)
ATC code
B01AB02
ATC class
Antithrombin III
Defined daily dose
2.1 TSD, E
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0085772
    1+1X20ML
    CZK 12195.92

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for antithrombin iii.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Antithrombin iii · interactions on record

112 records

  • 41 severe
  • 71 moderate

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ce45c3c3-088b-49cc-9613-52e94af5fb01
GET /v1/drugs/ce45c3c3-088b-49cc-9613-52e94af5fb01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ/INF PSO LQF",
  "source": "sukl",
  "strength": "50IU/ML",
  "pack_size": "1+1X20ML",
  "substance": "ANTITHROMBIN III + PROTEINS",
  "cz_kod_sukl": "0085772",
  "product_type": "KR/I",
  "substance_codes": "4729,3719",
  "registration_state": "R",
  "registration_number": "75/131/84-C"
}

See everything about antithrombin iii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.